# lamivudine

NDC: 31722-001
Generic name: lamivudine
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190321

FDA application: ANDA211306

## Active ingredients

- LAMIVUDINE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e90671c6-7fff-48f4-8898-29f02d049c8b